We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

LumiQuick Diagnostics

LumiQuick Diagnostics Inc. develops, manufactures and markets high quality point of care tests and other immunoassay ... read more Featured Products: More products

Download Mobile App





LumiQuick Showcases Expanded Testing Portfolio at MEDICA 2025

By LabMedica International staff writers
Posted on 18 Nov 2025

LumiQuick Diagnostics, Inc. More...

is showcasing its comprehensive range of rapid tests and immunoassay solutions at MEDICA 2025 from 17 to 20 November in Düsseldorf, Germany. Exhibiting in Hall 3, Stand D25-4, the company is presenting its newest developments across infectious-disease testing, drugs-of-abuse screening, cardiac and tumor markers, fertility and vitamin D assays.

LumiQuick’s exhibitor profile emphasizes its QuickProfile rapid-test lines, designed for point-of-care and laboratory use. The infectious-disease portfolio includes assays for malaria, dengue, Zika, chikungunya, influenza A/B, H. pylori, adenovirus, rotavirus, HIV, syphilis, and more, serving both tropical-disease settings and routine clinical workflows. The company’s QuickProfile portfolio also includes rapid tests for cardiac markers, cancer markers, and fertility hormones.

A major focus of the company is its extensive drugs-of-abuse (DOA) collection. The QuickProfile DOA lineup includes single test strips, single-drug card tests, multi-drug panels, and multi-panel cups that detect methamphetamine, cocaine, opiates, THC, fentanyl, synthetic cannabinoids, and many other substances.

At MEDICA 2025, LumiQuick is also highlighting the recently added Aoxre OxisResearch brand, which provides testing solutions for oxidative stress biomarkers, antioxidants, DNA damage, and related indicators. These products simplify the measurement of oxidative, antioxidant, nitrosative, and inflammatory biomarkers that play central roles in a wide range of diseases, including cancer, diabetes, cardiovascular disease, autism, atherosclerosis, stroke, Alzheimer’s, Parkinson’s, and other epidemiologic conditions.

Related Links:
Lumiquick Diagnostics, Inc.


New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.